Perturbation of cell-cell and cell-substratum adhesion by secreted and cell-surface proteases plays an important role in dissemination of epithelial tumors. Multiple recent DNA microarray studies identified cell-surface serine protease hepsin as a transcript that is drastically overexpressed in metastatic prostate carcinomas. We hypothesize that overexpression of hepsin causes disruption of cell-cell and cell-substratum adhesion in prostate epithelial cells and, therefore, contributes to prostate cancer progression. To analyze the functional significance of hepsin overexpression in the context of a prostate gland in vivo, we have generated and are now analyzing transgenic mice expressing hepsin in prostate epithelia. Since development of prostate carcinoma may require multiple genetic modifications, we will investigate potential cooperation between hepsin and other oncogenes. To determine potential role for hepsin at different time points of prostate cancer progression, we will breed our hepsin transgenic mice with mouse models of prostate cancer that develop precancerous prostate lesions, or nonmetastatic prostate cancer. We reason that if hepsin is positively involved in prostate cancer progression, overexpression of hepsin in the precancerous prostate lesions will lead to the development of prostate carcinoma. If hepsin is involved in cancer dissemination, overexpression of hepsin in the nonmetastatic prostate tumors will lead to a transition from nonmetastatic to metastatic cancer. To determine the molecular mechanisms responsible for hepsin function, we will analyze the primary prostate epithelial cell lines overexpressing this protein. Overall, the studies in this project will help to determine the functional significance and molecular consequences of hepsin overexpression in prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA102365-02
Application #
6891470
Study Section
Tumor Progression and Metastasis Study Section (TPM)
Program Officer
Woodhouse, Elizabeth
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$314,969
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Tang, Xi; Mahajan, Sumit S; Nguyen, Liem T et al. (2014) Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget 5:1352-62
Knudsen, Beatrice S; Vasioukhin, Valera (2010) Mechanisms of prostate cancer initiation and progression. Adv Cancer Res 109:1-50
Nandana, Srinivas; Ellwood-Yen, Katharine; Sawyers, Charles et al. (2010) Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model. Prostate 70:591-600
Chevillet, John R; Park, Gemma J; Bedalov, Antonio et al. (2008) Identification and characterization of small-molecule inhibitors of hepsin. Mol Cancer Ther 7:3343-51
Lee, Minhui; Vasioukhin, Valeri (2008) Cell polarity and cancer--cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 121:1141-50
Klezovitch, Olga; Risk, Michael; Coleman, Ilsa et al. (2008) A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci U S A 105:2105-10
Nechiporuk, Tamilla; Fernandez, Tania E; Vasioukhin, Valeri (2007) Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. Dev Cell 13:338-50
Klezovitch, Olga; Chevillet, John; Mirosevich, Janni et al. (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6:185-95